Shree Ganesh Biotech (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider and approve Pursuant to Regulation ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed the stock exchanges that its Board of Directors will meet on Friday, 25 July 2025. The main item on the agenda is to approve and take on record the un-audited financial results for the first quarter ended 30 June 2025 (Q1 FY26). The intimation has been filed under Regulation 29 of the SEBI (LODR) Regulations, 2015 to BSE, Calcutta Stock Exchange, and Metropolitan Stock Exchange. The notice has been signed by Director Aman Pravinkumar Patel and was dated 16 July 2025. No other major corporate action is mentioned on the agenda beyond the quarterly results.
This is a routine pre-results intimation. Shareholders and investors should watch for the company's Q1 FY26 earnings on 25 July 2025, which may influence short-term price movement based on the numbers reported.